1-3 of 3
Chunjiao Xu, MD, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

CKS1B Mediates SKP2/p27Kip1-Independent Myeloma Cell Survival and Disease Progression through Activation of MEK/ERK and JAK/STAT3 Signaling Pathways.

Fenghuang Zhan, MD, PhD, Lei Shi, MD, Siqing Wang, MD, MS, Hongwei Xu, MD, Thai M. Cao, MD, Chunjiao Xu, MD, PhD, Yong Wu, MD, PhD, Maurizio Zangari, MD, Guiyuan Li, MD, PhD, Guido J. Tricot, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 126.
https://doi.org/10.1182/blood.V114.22.126.126
Published: 2009
Journal Articles

Potential Eradication of Myeloma Stem Cells by Combining ATRA with WNT and HH Signaling Pathways Inhibitors.

Guido J. Tricot, MD, PhD, Siqing Wang, MD, MS, Lei Shi, MD, Hongwei Xu, MD, Chunjiao Xu, MD, PhD, Maurizio Zangari, MD, Fenghuang Zhan, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 2839.
https://doi.org/10.1182/blood.V114.22.2839.2839
Published: 2009
Journal Articles

Combination of ATRA with a COX2 Inhibitor Induces Synergistic Effects On RARalpha2-Expressing Multiple Myeloma (MM) Cells.

Siqing Wang, MD, MS, Lei Shi, MD, Hongwei Xu, MD, Chunjiao Xu, MD, PhD, Maurizio Zangari, MD, Guido J. Tricot, MD, PhD, Fenghuang Zhan, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 2809.
https://doi.org/10.1182/blood.V114.22.2809.2809
Published: 2009